Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexlansoprazole Dosing in H. Pylori Quadruple Therapy
NCT03087162Phase 4Completed
- Sponsor
- Ramathibodi Hospital
- Start
- Jan 2017
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexlansoprazole in Helicobacter pylori infection, sponsored by Ramathibodi Hospital. Started Jan 2017; status: completed.
02
Drugs
dexlansoprazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT03087162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03087162.